Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Epstein-Barr Virus Infections × Dexamethasone × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Multiple Myeloma 9 Neoplasms 6 Vomiting 5 Nausea 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm, Residual 2 Lymphoma 2 Wrist Fractures 1 Supratentorial Neoplasms 1 Radicular Cyst 1 Peripheral Nervous System Diseases 1 Pain, Postoperative 1 Ovarian Neoplasms 1 Malnutrition 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Leukemia, Biphenotypic, Acute 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Epstein-Barr Virus Infections 1 Dupuytren Contracture 1 Delirium 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Breast Cancer Patients Treated With T-DXd 1

Interventions

spartalizumab 1 ruxolitinib 1 dolutegravir 1 Ritonavir 1 Nucleosides 1 Dexamethasone 1 Darunavir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05039580 2021-09-09

SEHC

The First Affiliated Hospital of Soochow University

Phase 4 Unknown

Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡